There have been large numbers of studies on anti-HEV IgG seroprevalence in Europe,
however, the results of these studies have produced high variability of seroprevalence rates …

Hepatitis E was identified as an epidemic of non-A, non-B hepatitis from Kashmir, India in
1978. Hepatitis E virus (HEV), the etiological agent is the sole member of family …

1NHS Blood and Transplant, 2Imperial College Healthcare NHS Trust, London, 3University
College Hospitals NHS Trust, London, 4Serious Hazards of Transfusion, NHS Blood and …

The nomenclature of hepatitis E virus (HEV) subtypes is inconsistent and makes comparison
of different studies problematic. We have provided a table of proposed complete genome …

Most cases of hepatitis E viral (HEV) infection in developed countries are autochthonous.
Nevertheless, the reported seroprevalence of HEV varies greatly depending on the …

Hepatitis E is hyperendemic in many developing countries in Asia and Africa, and is caused
by hepatitis E virus (HEV) genotypes 1 and 2, which are spread via the faecal–oral route by …

Abstract Background Hepatitis E virus (HEV) is endemic in EU/EEA countries, but the
understanding of the burden of the infection in humans is inconsistent as the disease is not …

Hepatitis E virus (HEV), an RNA virus of the Hepeviridae family, has marked heterogeneity.
While all five HEV genotypes can cause human infections, genotypes HEV-1 and-2 infect …

Hepatitis E is a systemic disease affecting the liver predominantly and caused by infection
with the hepatitis E virus (HEV). HEV has marked genetic heterogeneity and is known to …

Viral hepatitis affects millions of people worldwide, and host immunity is the key determinant
of patient outcome. Viral hepatitis can be life threatening in patients with haematological …